Deep Dive

Views & Analysis

Clinical decision support tools will help oncologists manage...

Making treatment decisions is a tough choice for oncologists: a therapy might save or significantly extend one patient’s life but not deliver the desired outcome for another patient.

Views & Analysis

Solving immuno-oncology trial challenges in the COVID-19 era

The COVID-19 pandemic has placed immense stress on healthcare provision, but the emergency may also make major advances in cancer treatment even more relevant – if studies can continue to i

Views & Analysis

Making it as an oncology biotech in the united kingdom

Making it as an oncology biotech in the UK

We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem

Views & Analysis

Helping HCPs navigate the ever-evolving advanced cancer land...

OPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can help ensure maximum patient benefit

Views & Analysis

Adapting for the future of oncology

External pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace.

Views & Analysis

ASCO 2020: Scientific advances & what’s impacting doctors an...

Despite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Richard Staines that the 2020 American Society of Clini

Clinical decision support tools will help oncologists manage...

Solving immuno-oncology trial challenges in the COVID-19 era

Making it as an oncology biotech in the UK

Helping HCPs navigate the ever-evolving advanced cancer land...

Adapting for the future of oncology

ASCO 2020: Scientific advances & what’s impacting doctors an...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Deep Dive

Editor's Picks